EGFR and neoplasm: Our data showed that the injection of CAR-EXO-CTX notably inhibited the growth of tumours derived from MDA-MB-231 cells, whereas combined treatment of the exosomes with EGFR-Fc protein antibodies, but not with IgG isotype antibodies or HER2-Fc protein, reversed the effect (Fig. 5b).